Evidence map›Paper›PMID 41372113›Full record

ArticleCell death & disease2025

Photodynamic therapy simultaneously induces ferroptosis- and apoptosis-like lipid signatures in ovarian cancer cells.

Marta Overchuk, Albert M Choi, Brittany P Rickard, Brian Schnoor, Brandie M Ehrmann, Albert W Girotti, David A Zaharoff, Huang-Chiao Huang, Thomas M O'Connell, Shawn M Gomez and 1 more

Abstract read
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marta OverchukLampe Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA and North Carolina State University, Raleigh, NC, USA.ORCID http://orcid.org/0000-0002-8203-0427
Albert M ChoiLampe Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA and North Carolina State University, Raleigh, NC, USA.ORCID http://orcid.org/0009-0005-0490-8539
Brittany P RickardDepartment of Biological Sciences, North Carolina State University, Raleigh, NC, USA.ORCID http://orcid.org/0000-0002-6112-1290
Brian SchnoorFischell Department of Bioengineering, University of Maryland, College Park, MD, USA.
Brandie M EhrmannDepartment of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Albert W GirottiDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, USA.
David A ZaharoffLampe Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA and North Carolina State University, Raleigh, NC, USA.
Huang-Chiao HuangFischell Department of Bioengineering, University of Maryland, College Park, MD, USA.
Thomas M O'ConnellDepartment of Otolaryngology, Head and Neck Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.
Shawn M GomezLampe Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA and North Carolina State University, Raleigh, NC, USA.
Imran RizviLampe Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA and North Carolina State University, Raleigh, NC, USA. imran.rizvi@unc.edu.ORCID http://orcid.org/0000-0001-9673-4700

Funding

TOXICOLOGYT32ES007126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ILONA JASPERS, Bernard E. Weissman · 1985 to 2026
$13.0M
Integrating tumor and stroma to understand and predict treatment responseU01CA274298 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Naim Ur Rashid, Susan Tsai · 2022 to 2026
$4.7M
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)T32CA196589 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Gaorav P. Gupta, ALEXANDER V KABANOV · 2015 to 2026
$4.5M
IRON, NO, AND LIPID PEROXIDES IN PHOTODYNAMIC THERAPYR01CA070823 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI GIROTTI, ALBERT · 1997 to 2015
$3.5M
Addressing Chemoresistance in Pancreatic and Ovarian Cancers: Photodynamic Priming and Repurposing of Tetracyclines using Targeted Photo-Activable Multi-Inhibitor LiposomeR01CA260340 · NCI · UNIV OF MARYLAND, COLLEGE PARK · PI HUANG, HUANG CHIAO · 2021 to 2025
$3.2M
Targeting Fluid Stress-induced Chemoresistance in a 3D Carcinomatosis Perfusion Model Using Mechanism-based Photo-immunoconjugate NanoparticlesR01CA256710 · NCI · UNIV OF MARYLAND, COLLEGE PARK · PI Huang Chiao Huang, Imran Rizvi · 2023 to 2026
$2.2M
Advancing functional mass spectrometry imaging methodology to monitor dynamic physiological processesR01CA288969 · NCI · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI MICHAEL GAMCSIK, Shawn Gomez · 2025 to 2026
$930k
Photodynamic Alteration of Cell Membrane Lipids to Enhance Chemotherapy Efficacy in Metastatic Ovarian CancerK99CA300924 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI OVERCHUK, MARTA · 2025 to 2025
$117k
American Cancer Society (American Cancer Society, Inc.) PF-24-1198205-01-ETNCI NIH HHS K99 CA300924NCI NIH HHS R01 CA070823NCI NIH HHS R01 CA256710NCI NIH HHS R01 CA260340NCI NIH HHS R01 CA288969NCI NIH HHS T32 CA196589NCI NIH HHS U01 CA274298NIEHS NIH HHS T32 ES007126U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) CA70823U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) K99CA300924U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA256710U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA288969U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) U01CA274298
6 · The paper itself

Abstract

Resistance to apoptosis-inducing chemotherapy is a major factor contributing to treatment failure and poor survival outcomes in high-grade serous ovarian cancer (HGSOC). Ferroptosis, a regulated form of cell death driven by lipid peroxidation, has emerged as a promising effector mechanism because it remains available in HGSOC cells with impaired apoptosis signaling. While most research has focused on pharmacological ferroptosis inducers, there is growing interest in strategies that could trigger lipid autoxidation through externally delivered energy, such as photons. Photodynamic therapy (PDT), which utilizes light and light-activatable photosensitizers to generate reactive molecular species, offers a means of initiating lipid peroxidation with a high degree of precision and minimal systemic toxicities. However, the precise lipid targets of PDT, the influence of varying tumor lipidomic landscapes, and the role of ferroptosis sensitivity on PDT-lipid interactions have yet to be elucidated. In this study, we systematically compare PDT to ferroptosis induced by the inhibition of glutathione peroxidase 4, focusing on lipid redox states and composition in HGSOC cell lines. While PDT was similarly effective in both ferroptosis-sensitive and -resistant cells, its effects on cellular lipidomes differed markedly. PDT robustly induced lipid radical formation in both cell types; however, a dose-dependent accumulation of lipid hydroxides and hydroperoxides was only observed in ferroptosis-sensitive cells rich in unsaturated phospholipids. Further analysis revealed a significant overlap in lipid oxidation targets between PDT and ferroptosis. Notably, in both cell types, and in vivo, PDT upregulated ceramides, a lipid class strongly associated with mitochondrial apoptosis. In summary, PDT exhibited comparable efficacy in both ferroptosis-sensitive and -resistant cells by triggering a combination of lipid peroxidation and ceramide upregulation, suggesting the activation of both ferroptosis and apoptosis pathways. Further studies are needed to explore the role of PDT-induced lipidomic changes in the initiation of various cell death pathways and in overcoming chemoresistance in HGSOC.

Indexed as

ApoptosisFerroptosisOvarian NeoplasmsPhotochemotherapyAnimalsCell Line, TumorFemaleHumansLipid PeroxidationMicePhotosensitizing AgentsPhotosensitizing Agents

Identifiers

PMID41372113
PMCPMC12722221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.